Climacteric symptoms, gonadotrophins, sex steroids, and binding proteins with conjugated equine estrogen-progestin and tibolone over two years

Menopause

Volumn 3, Issue 4, 1996, Pages 208-213

  Milner, Maire ^a   Sinnott, Margaret ^b   Gasparo, Declan ^b   Kelly, Alan ^c   Carole, Barry Kinsella ^a   Harrison, Robert ^a  

^a ROTUNDA HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Endocrine; Estrogen progestin; Hormone replacement; Tibolone

Indexed keywords

EID: 0000954207     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-199603040-00007     Document Type: Article

References (13)

1. Chakravarti S, Collins WP, Forecast JD, Newton JR, Qram DH, Studd JW. Hormone profiles after the menopause. BMJ 1976;2:784-7.
2. Gow SM, Turner EI, Glasier A. The clinical biochemistry of the menopause and hormone replacement therapy. Ann Clin Biochem 1994;31:509-28.
3. Nishi T, Nakano R, Yagi S. Oestrogen feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women. Horm Res 1989;32:193-7.
4. Nakano R, Nishi T. Progesterone feedback in normal and sulpiride-induced hyperprolactinemic postmenopausal women. Obstet Gynecol 1989;73:617-21.
5. Cittadini J, Ben J, Badano AR, et al. The use of a new steroid in the climacteric syndrome. Reproduction 1982;6:69-79.
6. DeAloysio D, Fabiani AG, Mauloni M, Bottiglioni F. Use of Org OD 14 for the treatment of climacteric complaints. Maturitas 1987;SI:49-65.
7. Kicovic PM, Cortes-Prieto J, Luisi M, Milojevic S, Franchi F. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women. Reproduction 1981;6:81-91.
8. Lindsay PC, Shaw RW, Coelingh Bennink HJ, Kicovic P. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil Steril 1996;65:342-8.
9. Shaw R, Lindsay P. Randomised double-blind placebo-controlled trial of GnRH agonist triptorelin and livial in patients with endometriosis. In: Motta M, Serio M, eds. Sex hormones and antihormones in endocrine dependent pathology. Amsterdam: Elsevier, 1994:409-15.
10. Milner M, Sinnott MM, Cooke TM, Kelly A, McGill T, Harrison RF. A two-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin. Obstet Gynecol 1996;87:593-9.
11. Spielberger CD. Manual for the state-trait inventory. Palo Alto, CA: Consulting Psychologists' Press, 1983.
12. Geola FL, Frumar AM, Tataryn IV, et al. Biological effects of various doses of conjugated equine oestrogens in postmenpausal women. J Clin Endocrinol Metab 1980;51:620-5.
13. Mathur RS, Landgrebe SC, Moody LO, Semmens JP, Williamson HO. The effect of oestrogen treatment on plasma concentrations of steroid hormones, gonadotrophins, prolactin and SHBG in postmenopausal women. Maturitas 1985;7:129-34.